ARTICLE | Clinical News
Provigil modafinil: Phase III data
August 8, 2005 7:00 AM UTC
In a 3-month, double-blind, U.S. Phase III trial in 209 patients, 200 mg Provigil reduced sleepiness and significantly improved performance vs. placebo. Patients taking Provigil had modest improvement...